Literature DB >> 10750571

A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy.

A J Black1, J Topping, B Durham, R G Farquharson, W D Fraser.   

Abstract

The effects of pregnancy on bone turnover and the potential risk of developing an osteoporotic fracture in pregnancy are controversial. Utilizing biochemical markers of bone formation and resorption and dual-energy X-ray absorptiometry (DEXA), bone turnover before, during, and after pregnancy was studied in detail. Ten women (mean age 30 years; range 23-40) were recruited. Prepregnancy data were obtained and then a review was performed at 2-week intervals , once pregnancy was confirmed, until 14 weeks of gestation and thereafter monthly until term. Bone mineral density (BMD) was estimated by DEXA scanning of hip, spine, and forearm preconception and postpartum. In addition, BMD of the forearm at 14 weeks and 28 weeks gestation was obtained. All pregnancies had a successful outcome. Urinary free pyridinium cross-links, free pyridinoline (fPyr) and free deoxypyridinoline (fDPyr), were normal prepregnancy (mean [+/-SD]) 14.6 nmol/mmol (1.8) and 5.0 nmol/mmol (1.0) creat, respectively. By 14 weeks, they had increased to 20.8 nmol/mmol (4.3) and 6.1 nmol mmol (1.4) (both p < 0.02) and by 28 weeks to 26.3 nmol/mmol (5.6) and 7.4 nmol/mmol (1.6) (both p < 0.01). The ratio of fPyr to fDPyr remained constant. A similar significant increase was observed in N-telopeptide (NTx). Bone formation was assessed by measurement of carboxyterminal propeptide of type 1 collagen (P1CP) and bone-specific alkaline phosphatase (BSAP). Neither were altered significantly before 28 weeks, but subsequently mean P1CP increased from 110 microg/liter (23) to 235 microg/liter (84) at 38 weeks and mean BSAP increased from 11.1 U/liter (5.0) to 28.6 U/liter (11.1) (p < 0.01 for both variables). Lumbar spine (L1-L4) BMD decreased from a prepregnancy mean of 1.075 g/cm (0.115) to 1.054 g/cm2 (0.150) postpartum (p < 0.05). Total hip BMD decreased from a prepregnancy mean of 0.976 g/cm2 (0.089) to 0.941 g/cm2 (0.097) (p < 0.05). Forearm BMD at midradius, one-third distal and ultradistal decreased but did not reach statistical significance. As assessed by these bone markers, in the first 2 trimesters of pregnancy, bone remodeling is uncoupled with a marked increase in bone resorption. A corresponding increase in formation markers is not observed until the third trimester. Spinal BMD exhibits a significant decrease from prepregnancy to the immediate postpartum period with a mean reduction in BMD of 3.5 % in 9 months.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10750571     DOI: 10.1359/jbmr.2000.15.3.557

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  57 in total

1.  Parity and risk of hip fracture in postmenopausal women.

Authors:  M Kauppi; M Heliövaara; O Impivaara; P Knekt; A Jula
Journal:  Osteoporos Int       Date:  2010-10-06       Impact factor: 4.507

2.  Lack of evidence for prescription of antepartum bed rest.

Authors:  Judith A Maloni
Journal:  Expert Rev Obstet Gynecol       Date:  2011-07-01

3.  Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses.

Authors:  D Holmberg-Marttila; A Leino; H Sievänen
Journal:  Osteoporos Int       Date:  2003-02-12       Impact factor: 4.507

4.  Serum 1,25-dihydroxyvitamin D and calcium intake affect rates of bone calcium deposition during pregnancy and the early postpartum period.

Authors:  Kimberly O O'Brien; Carmen M Donangelo; Lorrene D Ritchie; Ginny Gildengorin; Steve Abrams; Janet C King
Journal:  Am J Clin Nutr       Date:  2012-05-30       Impact factor: 7.045

5.  The effects of metallothionein 2A polymorphism on lead metabolism: are pregnant women with a heterozygote genotype for metallothionein 2A polymorphism and their newborns at risk of having higher blood lead levels?

Authors:  Deniz Tekin; Zeliha Kayaaltı; Tülin Söylemezoğlu
Journal:  Int Arch Occup Environ Health       Date:  2011-10-18       Impact factor: 3.015

6.  Maternal plasma osteoprotegerin concentration in normal pregnancy.

Authors:  Joon-Seok Hong; Joaquin Santolaya-Forgas; Roberto Romero; Jimmy Espinoza; Luís F Gonçalves; Yeon Mee Kim; Samuel Edwin; Bo Hyun Yoon; Jyh Kae Nien; Sonia Hassan; Moshe Mazor
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

Review 7.  Heat shock protein 10 and signal transduction: a "capsula eburnea" of carcinogenesis?

Authors:  Anna M Czarnecka; Claudia Campanella; Giovanni Zummo; Francesco Cappello
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

8.  Continuing education module-maternal calcium intake and metabolism during pregnancy and lactation.

Authors:  Julie Heringhausen; Kristen S Montgomery
Journal:  J Perinat Educ       Date:  2005

9.  A case of teriparatide on pregnancy-induced osteoporosis.

Authors:  Seok Hong Lee; Moon-Ki Hong; Seung Won Park; Hyoung-Moo Park; Jaetaek Kim; Jihyun Ahn
Journal:  J Bone Metab       Date:  2013-11-18

10.  Low mineral density of a weight-bearing bone among adult women in a high fertility population.

Authors:  Jonathan Stieglitz; Bret A Beheim; Benjamin C Trumble; Felicia C Madimenos; Hillard Kaplan; Michael Gurven
Journal:  Am J Phys Anthropol       Date:  2014-12-08       Impact factor: 2.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.